.png)
AS Malaysia looks forward to the upcoming school holidays, the rising tide of Covid-19 cases in neighbouring countries such as Singapore and Thailand should serve as a timely warning against complacency.
In recent weeks, both countries have reported a marked resurgence of infections. Singapore has registered a sharp jump in cases, while Thailand has seen numbers double in a matter of days.
Given Malaysia’s proximity and strong cross-border travel with both nations – whether for work, tourism or family visits – the risk of imported infections cannot be ignored, especially during the holiday season when thousands are expected to travel to destinations like Hat Yai and Orchard Road.
The question now is whether Malaysia will heed the warning signs, or wait until local case numbers surge once more.
While the Ministry of Health has advised the public to resume wearing face masks in crowded spaces and to remain cautious, anecdotal evidence suggests many have returned to pre-pandemic behaviours, dismissing Covid-19 as a thing of the past.
But the virus is far from retired. With its ability to evolve, including into subvariants such as JN.1 – now spreading across Asia – it continues to pose a threat, particularly to the elderly and immunocompromised.
The public need not revert to full personal protective equipment (PPE), but simple measures can go a long way: frequent hand washing, avoiding crowded areas when ill, wearing a mask in enclosed spaces, and monitoring one’s health after returning from overseas.
Equally, those who are unwell should exercise responsibility and avoid sharing their illness with others.
Travelling abroad is not discouraged, but returning travellers should self-monitor and seek medical attention if symptoms develop. As the saying goes, prevention is still better than cure.
Global reports reveal a fresh wave of Covid-19 infections is sweeping through parts of Southeast Asia, prompting public health authorities in Hong Kong, Singapore, Thailand and China to urge renewed vigilance and encourage booster vaccinations.
In Hong Kong, virus activity is currently “quite high”, according to the Centre for Health Protection. The city recently recorded its highest Covid positivity rate in a year, with 31 severe cases reported in the week ending 3 May – the highest in 12 months. Increases in viral load in sewage samples, hospitalisations and medical consultations all point to an active spread of the virus among the city’s 7 million residents.
Singapore has also seen a sharp uptick, with Covid-19 cases rising 28 per cent to 14,200 in the week ending 3 May. Daily hospitalisations have increased by around 30 per cent. The Ministry of Health noted that this is the first time in nearly a year that Singapore has released such figures, as regular updates are now only issued during significant spikes.
“While the increase in cases could be due to factors including waning population immunity, there is no indication that the circulating variants are more transmissible – or cause more severe cases – than during the pandemic,” the ministry stated.
In Thailand, the Department of Disease Control reported 33,030 new Covid-19 infections in the week ending 17 May – a twofold increase from the previous week’s 16,000 cases. Bangkok recorded the highest number of cases, followed by Chon Buri, Rayong and Nonthaburi. Most infections were in individuals aged 30 to 39. Health officials believe the post-Songkran period, which involved widespread public gatherings, contributed to the spike.
China is also seeing a resurgence. Between 31 March and 4 May, the Covid-19 positivity rate among outpatient and emergency influenza-like cases rose from 7.5 per cent to 16.2 per cent, while the rate among hospitalised cases doubled to 6.3 per cent, according to the China Center for Disease Control and Prevention.
India has reported a modest increase in active cases, with 257 cases nationwide, but health authorities say there is no indication of a wider outbreak at this stage.
The recent surge across the region is being attributed to the spread of the JN.1 variant – a descendant of the Omicron lineage. The World Health Organization has designated JN.1 as a “variant of interest”, indicating that it is under close observation, though it has not yet been classified as a “variant of concern”.
So far, no evidence suggests that JN.1 causes more severe illness than earlier Omicron subvariants. Nevertheless, governments across the region are urging caution, particularly for vulnerable groups, and calling on the public to remain up to date with booster vaccinations. - May 21, 2025
